跳至主要内容
临床试验/NCT02394379
NCT02394379已完成不适用

A Prospective, Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber Intraocular Lens (IOL)

Bausch & Lomb Incorporated1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2015年3月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
600
试验地点
1
主要终点
Incidence of clinically significant IOL vaulting

研究概览

简要总结

To evaluate the incidence of IOL vaulting (ie, position change) of the Trulign™ Toric IOL following cataract surgery.

详细描述

The objective of this post approval safety study is to evaluate the incidence of IOL vaulting (ie, position change) of the Trulign™ Toric IOL following cataract surgery at up to three years post implantation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Subjects who are able and willing to comply with the follow-up schedule
  • Subjects must have a clinically documented diagnosis of age-related cataract that is considered amenable to treatment with standard phacoemulsification/extracapsular cataract extraction
  • Subjects must require a lens power from 4 to 33 D
  • Subjects must have a Best Corrected Visual Acuity (BCVA) equal to or worse than 20/40, with or without a glare source

排除标准

  • Subjects with any anterior segment pathology in the study eye likely to increase the risk of complications from phacoemulsification cataract surgery
  • Subjects with associated ocular conditions which could affect the stability of the IOL
  • Subjects with clinically significant irregular corneal astigmatism in the study eye

结局指标

主要结局

Incidence of clinically significant IOL vaulting

时间窗: Up to 3 years

IOL vaulting is position change such as clinically significant anterior vaulting, clinically significant tilt, and secondary surgical intervention related to such vaulting. The proportion of study eyes experiencing vaulting will be estimated by Kaplan-Meier method.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验